Abstract |
A 14-year-old girl with juvenile dermatomyositis developed extensive and debilitating calcinosis, unresponsive to colchicine, while muscle involvement subsided. Pamidronate (2mg/kg/year) produced dramatic improvement of pain and function within 2 months and calcinosis had completely resolved by 2 years. No new calcifications have been noted with a 5-year follow-up.
|
Authors | Samy Slimani, Amina Abdessemed, Assia Haddouche, Aicha Ladjouze-Rezig |
Journal | Joint bone spine
(Joint Bone Spine)
Vol. 77
Issue 1
Pg. 70-2
(Jan 2010)
ISSN: 1778-7254 [Electronic] France |
PMID | 20031471
(Publication Type: Case Reports, Journal Article)
|
Copyright | Copyright 2009 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved. |
Chemical References |
- Bone Density Conservation Agents
- Diphosphonates
- Cholecalciferol
- Pamidronate
- Calcium
- Methylprednisolone
|
Topics |
- Adolescent
- Bone Density Conservation Agents
(therapeutic use)
- Calcinosis
(diagnostic imaging, drug therapy, etiology)
- Calcium
(administration & dosage)
- Cholecalciferol
(administration & dosage)
- Dermatomyositis
(complications, diagnostic imaging, drug therapy)
- Diphosphonates
(therapeutic use)
- Drug Therapy, Combination
- Female
- Humans
- Methylprednisolone
(therapeutic use)
- Pamidronate
- Radiography
- Recovery of Function
- Treatment Outcome
|